MikeTrendsTrends right now

search

drug laws

Trends

  1. 1
    Spanish patrol captain orders retreat from drug-smuggling speedboats●“They are going to kill us.” A patrol captain in Spain orders a retreat in Europe’s losing battle against drug-smuggling𝕏xESWorldCrime3352 h ago

    A patrol captain in Spain ordered his team to withdraw, saying 'They are going to kill us', in an encounter with drug-smuggling speedboats that outrun authorities and deliver cocaine by the ton. The incident is being cited as a symbol of Europe's losing battle against maritime narcotics trafficking along the Spanish coast.

  2. 2
    Idaho church cold case man linked to 1982 Tylenol poisonings●Man found dead in Idaho church 40 years ago linked to 1982 Tylenol poisonings▶youtubeWorldReligion472K12 min ago

    Investigators have linked a man found dead in an Idaho church roughly 40 years ago to the 1982 Chicago-area Tylenol poisonings that killed seven people and reshaped US drug packaging laws. Authorities say new evidence ties the unidentified man to the unsolved case, reviving one of America's most notorious criminal mysteries more than four decades later.

  3. 3
    After the Drug Laws: What Comes Next for Marijuana Policy●After the Drug Laws https://www.nytimes.com/2026/09/27/briefing/after-the-drug-laws.html # News # Marijuana # LawMmastodonWorld323 h ago

    The New York Times' briefing examines the aftermath of recent drug laws, focusing on marijuana policy and its legal consequences. The piece explores how changes in drug legislation are reshaping law enforcement, regulation and public attitudes. Readers are discussing the broader implications of these shifts for national drug policy.

  4. 4

    Biotech company Disc Medicine is the subject of investor investigations following an FDA letter connected to its drug development work. Law firms and shareholder groups are reportedly looking into whether the company made misleading statements about regulatory progress. The news has put pressure on the stock and left investors watching for further disclosures about the FDA's concerns.